Cubist Systematic Strategies, LLC Poseida Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.83 - $3.51 $5,103 - $9,789	2,789 Added 20.35%	16,495 $55,000
Q3 2023 Nov 14, 2023	SELL	$1.62 - $2.79 $61,629 - $106,139	-38,043 Reduced 73.51%	13,706 $32,000
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.4 $400,013 - $819,304	-240,972 Reduced 82.32%	51,749 $91,000
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $638,108 - $1.81 Million	207,178 Added 242.19%	292,721 $901,000
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $233,209 - $446,810	70,033 Added 451.53%	85,543 $453,000
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $37,689 - $69,950	15,510 New	15,510 $55,000
Q1 2022 May 16, 2022	SELL	$3.22 - $7.04 $75,451 - $164,961	-23,432 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.23 - $7.6 $145,981 - $178,083	23,432 New	23,432 $160,000

103

38.7M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.